A Randomised, Repeat-dose, Placebo-controlled, Three-way Crossover, Double Dummy Study to Evaluate and Compare the Efficacy of Fluticasone Furoate Inhalation Powder Delivered Via the Single Strip Dry Powder Inhaler When Administered Either in the Morning or in the Evening, in Male and Female Asthmatic Subjects
Phase of Trial: Phase II
Latest Information Update: 15 May 2015
At a glance
- Drugs Fluticasone furoate (Primary)
- Indications Asthma
- Focus Therapeutic Use
- Sponsors GlaxoSmithKline
- 28 Mar 2014 According to ClinicalTrials.gov record, status changed from active, no longer recruiting to completed.
- 13 Feb 2014 According to ClinicalTrials.gov record, status changed from recruiting to active, no longer recruiting.
- 18 Mar 2013 New trial record